Literature DB >> 30390364

A Study of the Correlation of Perfusion Parameters in High-Resolution GRASP MRI With Microvascular Density in Lung Cancer.

Lihua Chen1,2, Xianchun Zeng3, Youli Wu4, Xiaochu Yan4, Xuequan Huang1, Hui Chen1, Jiuquan Zhang5,6, Jian Wang1, Li Feng7.   

Abstract

BACKGROUND: The histological count of microvascular density (MVD) is the current clinical standard for assessing tumor angiogenesis. Although it is hypothesized that perfusion MRI can be a noninvasive alternative to MVD, there have been few studies to validate their correlations, particularly in lung cancer.
PURPOSE: To investigate the correlation between MVD and perfusion parameters obtained from high-resolution GRASP (Golden-angle RAdial Sparse Parallel) dynamic contrast-enhanced (DCE)-MRI in a cohort of lung cancer patients, and to validate that GRASP MRI can serve as a free-breathing, noninvasive imaging approach for studying tumor angiogenesis. STUDY TYPE: Prospective. POPULATION: Twenty-five lung cancer patients (16 male, 9 female, mean age = 57.3 ± 11.7 years). FIELD STRENGTH/SEQUENCE: 3T MRI; a prototype golden-angle stack-of-stars sequence. ASSESSMENT: Contrast-enhanced MR data were acquired during free breathing and were reconstructed using GRASP with a temporal resolution of ∼3 sec/phase. For all data, perfusion analysis was performed using a standard Tofts model to generate the volume transfer coefficient (Ktrans ) and the interstitial volume (Ve ). The MVD of corresponding tumor specimens, obtained from Computed Tomography-guided biopsies, were counted with CD34 staining. STATISTICAL TESTS: Pearson correlation analysis; one-way analysis of variance analysis; least significant difference-t method of multiple comparisons.
RESULTS: The correlation coefficient was 0.983 and 0.972 for the measurement and remeasurement of Ktrans and Ve . The mean values of Ktrans , Ve , and MVD were 0.33 ± 0.22 min-1 , 0.25 ± 0.12, and 49.68 ± 27.08 vessels/0.723 mm2 , respectively, in all patients (n = 25); 0.36 ± 0.26 min-1 , 0.27 ± 0.13, and 49.09 ± 29.84 vessels/0.723 mm2 , respectively, in adenocarcinoma (n = 15); 0.34 ± 0.17 min-1 , 0.26 ± 0.12, and 53.85 ± 23.53 vessels/0.723 mm2 , respectively, in squamous cell carcinoma (n = 8); and 0.13 ± 0.15 min-1 , 0.14 ± 0.06, and 37.20 ± 28.28 vessels/0.723 mm2 , respectively, in small-cell carcinoma (n = 2). There was a positive relationship between the Ktrans and MVD in all patients (r = 0.738, P < 0.001). DATA
CONCLUSION: High spatiotemporal resolution DCE-MRI using GRASP is a promising noninvasive alternative to the histological count of MVD for assessing tumor angiogenesis in lung cancer. LEVEL OF EVIDENCE: 1 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;49:1186-1194.
© 2018 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  GRASP; compressed sensing; free-breathing; golden-angle radial; lung cancer; microvascular density

Year:  2018        PMID: 30390364     DOI: 10.1002/jmri.26340

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  3 in total

1.  Pulmonary lesions: correlative study of dynamic triple-phase enhanced CT perfusion imaging with tumor angiogenesis and vascular endothelial growth factor expression.

Authors:  Mingyue Zou; Zhenhua Zhao; Bingqian Zhang; Haijia Mao; Yanan Huang; Cheng Wang
Journal:  BMC Med Imaging       Date:  2021-10-30       Impact factor: 1.930

2.  Magnetic Resonance Imaging Segmentation on the Basis of Boundary Tracking Algorithm in Lung Cancer Surgery.

Authors:  Chengmin Liu; Fulin Ye; Yikai Hu; Shengxin Gao; Yu Lu; Yilong Guo
Journal:  Contrast Media Mol Imaging       Date:  2021-11-08       Impact factor: 3.161

Review 3.  Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates.

Authors:  Marieke A Stammes; Ji Hyun Lee; Lisette Meijer; Thibaut Naninck; Lara A Doyle-Meyers; Alexander G White; H Jacob Borish; Amy L Hartman; Xavier Alvarez; Shashank Ganatra; Deepak Kaushal; Rudolf P Bohm; Roger le Grand; Charles A Scanga; Jan A M Langermans; Ronald E Bontrop; Courtney L Finch; JoAnne L Flynn; Claudia Calcagno; Ian Crozier; Jens H Kuhn
Journal:  Trends Mol Med       Date:  2021-12-07       Impact factor: 15.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.